The efficacy of hyperbaric oxygen for the treatment of experimental uveitis induced in rabbits

Ocular Immunology and Inflammation

Volumn 13, Issue 5, 2005, Pages 383-388

  Erşanli, Dilaver ^a   Karadayi, Koray ^a   Toyran, Sami ^a   Akin, Tugrul ^a   Sönmez, Murat ^a   Çiftçi, Ferda ^a   Top, Cihan ^a   Elbüken, Emin ^a  

^a GATA HAYDARPASA TRAINING HOSPITAL   (Turkey)

Author keywords

Experimental uveitis; Hyperbaric oxygen; Rabbits

Indexed keywords

ENDOTOXIN; LIPOPOLYSACCHARIDE; METHYLPREDNISOLONE ACETATE; PREDNISOLONE ACETATE; PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AQUEOUS HUMOR; ARTICLE; CELL COUNT; CONTROLLED STUDY; HYPERBARIC OXYGEN; INFLAMMATION; MICROSCOPY; NONHUMAN; RABBIT; REMISSION; SALMONELLA TYPHIMURIUM; SCORING SYSTEM; STATISTICAL ANALYSIS; UVEITIS;

ACUTE DISEASE; ANIMALS; DISEASE MODELS, ANIMAL; HYPERBARIC OXYGENATION; LIPOPOLYSACCHARIDES; RABBITS; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; UVEITIS, ANTERIOR;

EID: 28244488549     PISSN: 09273948     EISSN: 17445078     Source Type: Journal    
DOI: 10.1080/09273940490912425     Document Type: Article

References (17)

1. Singh VK, Biswas S, Anand R, Agarwal SS. Experimental autoimmune uveitis as animal model for human posterior uveitis. Indian J Med Res. 1998;107:53-67.
2. Forrester JV, Liversidge J, Dua HS, Towler H, McMenamin PG. Comparison of clinical and experimental uveitis. Curr Eye Res. 1990;9(Suppl):75-84.
3. Caspi RR. Immunogenetic aspects of clinical and experimental uveitis. Reg Immunol. 1992;4(5):321-330.
4. Tibbles PM, Edelsberg JS. Hyperbaric oxygen therapy. N Engl J Med. 1996;334:1642-1648.
5. Camporesi EM, ed. Hyperbaric Oxygen Therapy Committee Report. Kensington, MD: Undersea and Hyperbaric Medical Society, 1996.
6. Lightman S, Kok H. Developments in the treatment of uveitis. Expert Opin Invest Drugs. 2002; 11(1):59-67.
7. Rosenberg WM, Moss PA, Bell JI. Molecular aspects of autoimmunity: a review. Curr Eye Res. 1992;11(Suppl):17-23.
8. Careless DJ, Inman RD. Acute anterior uveitis: clinical and experimental aspects. Semin Arthritis Rheum. 1995;24(6):432-441.
9. Smith JR, Hart PH, Williams KA. Basic pathogenic mechanisms operating in experimental models of acute anterior uveitis. Immunol Cell Biol. 1998;76(6):497-512.
10. Howes Jr EL, Cole PW, Adair TM, Cruse VK, Pollycove M. Cellular and vascular responses in acute experimental ocular inflammation. Invest Ophthalmol Vis Sci. 1994;35(12):4031-4038.
11. Helbig H, Kittredge KL, Gurley RC, Thurau SR, Palestine AG, Nussenblatt RB. Endotoxin-induced production of inflammatory mediators by cultured ciliary epithelial cells. Curr Eye Res. 1990;9(5):501-505.
12. Csukas S, Paterson CA, Brown K, Bahatterjee P. Time course of rabbit ocular inflammatory response and mediator release after intravitreal endotoxin. Invest Ophthalmol Vis Sci. 1990;31:382-387.
13. Okamoto N, Nishimura Y, Goami K, Harino S. Effect of hyperbaric oxygen on ophthalmic artery blood velocity in patients with diabetic neuropathy. Jpn J Ophthalmol. 1998;42(5):406-410.
14. Kuroki AM, Kitaoka T, Tanuguchi H, Amemiya T. Hyperbaric oxygen therapy reduces visual field defect after macular hole surgery. Ophthalmic Surg Lasers. 2002;33:200-206.
15. Speit G, Dennog C, Eichhorn U, Rothfuss A, Kaina B. Induction of heme oxygenase-1 and adaptive protection against the induction of DNA damage after hyperbaric oxygen treatment. Carcinogenesis. 2000;21(10):1795-1799.
16. Yildrim G, Bastug M, Akcil IE, Ficicilar H, Koc E, Zaloglu N. Does the platelet activating factor affect the antioxidant defense system? The possible role of hyperbaric oxygenation, Biol Trace Elem Res. 2000;78(1-3):7-12.
17. Dennog C, Radermacher P, Barnett YA, Speit G. Antioxidant status in humans after exposure to hyperbaric oxygen. Mutat Res. 1999;428(1-2):83-89.